LEO PHARMA AS

1364 FORNEBU

Finances

Share Ownership

Return on Equity

9,83 %

Current Ratio

1,93

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	79 203 000	54 067 000	74 342 000	73 267 000
Net Income	1 564 000	528 000	2 400 000	1 928 000
Total Assets	33 044 000	29 475 000	21 707 000	29 006 000
Total Equity	15 912 000	14 349 000	13 820 000	11 421 000

Income (NOK)	2022	2021	2020	2019
Revenue	79 203 000	54 067 000	74 342 000	73 267 000
Expenditure	77 583 000	53 344 000	71 236 000	71 533 000
Operating Profit	1 621 000	723 000	3 105 000	1 734 000
Financial Income	521 000	43 000	52 000	804 000
Financial Costs	131 000	82 000	74 000	43 000
Financial Balance	390 000	−39 000	−22 000	761 000
Earnings Before Tax	2 011 000	684 000	3 083 000	2 495 000
Tax	447 000	156 000	683 000	567 000
Net Income	1 564 000	528 000	2 400 000	1 928 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	4 000	8 000	10 000	9 000
Total Current Assets	33 040 000	29 468 000	21 697 000	28 997 000
Total Assets	33 044 000	29 475 000	21 707 000	29 006 000
Total Retained Equity	7 012 000	5 449 000	4 920 000	2 521 000
Total Equity	15 912 000	14 349 000	13 820 000	11 421 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	17 131 000	15 127 000	7 887 000	17 585 000
Total Equity and Debt	33 044 000	29 475 000	21 707 000	29 006 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	48 996 000	54 067 000	74 342 000	73 267 000
Other Income	30 208 000	0	0	0
Revenue	79 203 000	54 067 000	74 342 000	73 267 000
Cost of Goods Sold	55 374 000	51 698 000	57 121 000	59 643 000
Salary Costs	10 307 000	10 436 000	8 625 000	6 668 000
Depreciation	0	0	0	20 000
Impairment	0	0	0	0
Expenditure	77 583 000	53 344 000	71 236 000	71 533 000
Operating Profit	1 621 000	723 000	3 105 000	1 734 000
Financial Income	521 000	43 000	52 000	804 000
Financial Costs	131 000	82 000	74 000	43 000
Financial Balance	390 000	−39 000	−22 000	761 000
Dividends	0	0	0	0
Net Income	1 564 000	528 000	2 400 000	1 928 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	4 000	8 000	10 000	9 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	4 000	8 000	10 000	9 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	0	0	7 683 000	2 777 000
Total Current Assets	33 040 000	29 468 000	21 697 000	28 997 000
Total Assets	33 044 000	29 475 000	21 707 000	29 006 000
Total Equity	15 912 000	14 349 000	13 820 000	11 421 000
Short-Term Group Debt	1 607 000	1 607 000	0	0
Total Long-Term Debt	0	0	0	0
Creditors	9 790 000	2 412 000	798 000	9 551 000
Unpaid Taxes	2 754 000	2 908 000	3 431 000	4 879 000
Dividends	0	0	0	0
Other Current Debt	2 537 000	8 046 000	2 973 000	2 786 000
Total Current Debt	17 131 000	15 127 000	7 887 000	17 585 000
Total Equity and Debt	33 044 000	29 475 000	21 707 000	29 006 000

Financial indicators	2022	2021	2020	2019
Return on Equity	9,83 %	3,68 %	17,37 %	16,88 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	2,05 %	1,34 %	4,18 %	2,37 %
Current Ratio	1,93	1,95	2,75	1,65
Quick Ratio	1,93	1,95	2,75	1,65
Equity Ratio	0,48	0,49	0,64	0,39
Gross Profit Margin	30,09 %	4,38 %	23,16 %	18,6 %